|
1
|
Jemal A, Bray F, Center MM, et al: Global
cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar
|
|
2
|
Erridge SC, Møller H, Price A and Brewster
D: International comparisons of survival from lung cancer: pitfalls
and warnings. Nat Clin Pract Oncol. 4:570–577. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Efferth T, Li PC, Konkimalla VS and Kaina
B: From traditional Chinese medicine to rational cancer therapy.
Trends Mol Med. 13:353–361. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Harvey AL: Natural products in drug
discovery. Drug Discov Today. 13:894–901. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hanson JR: Diterpenoids. Nat Product Rep.
26:1156–1171. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cheng SY, Chuang CT, Wang SK, et al:
Antiviral and anti-inflammatory diterpenoids from the soft coral
Sinularia gyrosa. J Nat Prod. 73:1184–1187. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hsieh TC, Wijeratne EK, Liang JY, et al:
Differential control of growth, cell cycle progression, and
expression of NF-kappa B in human breast cancer cells MCF-7,
MCF-10A, and MDA-MB-231 by ponicidin and oridonin, diterpenoids
from the chinese herb Rabdosia rubescens. Biochem Biophys
Res Commun. 337:224–231. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang SP, Dong L, Wang Y, et al: Antifungal
diterpenoids of Pseudolarix kaempferi, and their
structure-activity relationship study. Bioorg Med Chem.
11:4577–4584. 2003.PubMed/NCBI
|
|
9
|
Duan HQ, Takaishi Y, Momota H, et al:
Immunosuppressive diterpenoids from Tripterygium wilfordii.
J Nat Prod. 62:1522–1525. 1999. View Article : Google Scholar
|
|
10
|
Trost BM, Waser J and Meyer A: Total
synthesis of (−)-pseudolaric acid B. J Am Chem Soc.
130:16424–16434. 2008.
|
|
11
|
Li E, Clark AM and Hufford CD: Antifungal
evaluation of pseudolaric acid B, a major constituent of
Pseudolarix kaempferi. J Nat Prod. 58:57–67. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu B, Chen H, Lei ZY, Yu PF and Xiong B:
Studies on anti-tumour activities of pseudolaric acid-B (PLAB) and
its mechanism of action. J Asian Nat Prod Res. 8:241–252. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li T, Wong VK, Yi XQ, et al: Pseudolaric
acid B suppresses T lymphocyte activation through inhibition of
NF-kappa B signaling pathway and p38 phosphorylation. J Cell
Biochem. 108:87–95. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Meng AG and Jiang LL: Pseudolaric acid
B-induced apoptosis through p53-dependent pathway in human gastric
carcinoma cells. J Asian Nat Prod Res. 11:142–152. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li MH, Miao ZH, Tan WF, et al: Pseudolaric
acid B inhibits angiogenesis and reduces hypoxia-inducible factor
1alpha by promoting proteasome-mediated degradation. Clin Cancer
Res. 10:8266–8274. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gong XF, Wang MW, Wu Z, et al: Pseudolaric
acid B induces apoptosis via activation of c-Jun N-terminal kinase
and caspase-3 in HeLa cells. Exp Mol Med. 36:551–556. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gong XF, Wang MW, Tashiro S, et al:
Involvement of JNK-initiated p53 accumulation and phosphorylation
of p53 in pseudolaric acid B induced cell death. Exp Mol Med.
38:428–434. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gong XF, Wang MW, Tashiro S, et al:
Pseudolaric acid B induces apoptosis through p53 and Bax/Bcl-2
pathways in human melanoma A375-S2 cells. Arch Pharm Res. 28:68–72.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li KS, Gu XF, Li P, et al: Effect of
pseudolaric acid B on gastric cancer cells: inhibition of
proliferation and induction of apoptosis. World J Gastroenterol.
11:7555–7559. 2005.PubMed/NCBI
|
|
20
|
Wu WY, Guo HZ, Qu GQ, et al: Mechanisms of
pseudolaric acid B-induced apoptosis in Bel-7402 cell lines. Am J
Chin Med. 34:887–899. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yu JH, Cui Q, Jiang YY, et al: Pseudolaric
acid B induces apoptosis, senescence, and mitotic arrest in human
breast cancer MCF-7. Acta Pharmacol Sin. 28:1975–1983. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yu JH, Wang HJ, Li XR, et al: Protein
tyrosine kinase, JNK, and ERK involvement in pseudolaric acid
B-induced apoptosis of human breast cancer MCF-7 cells. Acta
Pharmacol Sin. 29:1069–1076. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yu J, Li X, Tashiro S, et al: Bcl-2 family
proteins were involved in pseudolaric acid B-induced autophagy in
murine fibrosarcoma L929 cells. J Pharmacol Sci. 107:295–302. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Qi M, Yao G, Fan S, et al: Pseudolaric
acid B induces mitotic catastrophe followed by apoptotic cell death
in murine fibrosarcoma L929 cells. Eur J Pharmacol. 683:16–26.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ma G, Chong L, Li XC, et al: Selective
inhibition of human leukemia cell growth and induction of cell
cycle arrest and apoptosis by pseudolaric acid B. J Cancer Res Clin
Oncol. 136:1333–1340. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhao D, Lin F, Wu X, et al: Pseudolaric
acid B induces apoptosis via proteasome-mediated Bcl-2 degradation
in hormone-refractory prostate cancer DU145 cells. Toxicol In
Vitro. 26:595–602. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Khan M, Zheng B, Yi F, et al: Pseudolaric
acid B induces caspase-dependent and caspase-independent apoptosis
in U87 glioblastoma cells. Evid Based Complement Alternat Med.
2012:9575682012.PubMed/NCBI
|
|
28
|
Thompson CB: Apoptosis in the pathogenesis
and treatment of disease. Science. 267:1456–1462. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lowe SW and Lin AW: Apoptosis in cancer.
Carcinogenesis. 21:485–495. 2000. View Article : Google Scholar
|
|
30
|
Huang DM, Shen YC, Wu C, et al:
Investigation of extrinsic and intrinsic apoptosis pathways of new
clerodane diterpenoids in human prostate cancer PC-3 cells. Eur J
Pharmacol. 503:17–24. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cheung HY, Cheung SH, Li JL, et al:
Andrographolide isolated from Andrographis paniculata
induces cell cycle arrest and mitochondrial-mediated apoptosis in
human leukemic HL-60 cells. Planta Med. 71:1106–1111.
2005.PubMed/NCBI
|
|
32
|
Korsmeyer SJ: BCL-2 gene family and the
regulation of programmed cell death. Cancer Res. 59(Suppl 7):
1693s–1700s. 1999.PubMed/NCBI
|
|
33
|
Jiao Y, Ge CM, Meng QH, et al:
Dihydroartemisinin is an inhibitor of ovarian cancer cell growth.
Acta Pharmacol Sin. 28:1045–1056. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang JB, Qi LL, Zheng SD and Wu TX:
Curcumin induces apoptosis through the mitochondria-mediated
apoptotic pathway in HT-29 cells. J Zhejiang Univ Sci B. 10:93–102.
2009. View Article : Google Scholar
|
|
35
|
Wu SJ, Ng LT, Lin DL, et al: Physalis
peruviana extract induces apoptosis in human Hep G2 cells
through CD95/CD95L system and the mitochondrial signaling
transduction pathway. Cancer Lett. 215:199–208. 2004. View Article : Google Scholar
|
